Following the close of market, biotech stock investors were excited and filled with a new breath of reassurance for their investment holdings in Cell Therapuetics (NASDAQ:CTIC) and Hemispherx Biopharma (AMEX:HEB) today. Given a sharp boost by their inclusion today in the Russell 3000, Cell Therapeutics closed at $1.85 (+0.28 +17.83%) while Hemispherx took the stage at $2.85 (+0.45 +18.75%).
The real buzz and excitement followed after hours for Hemispherx investors. Reports of after hou... Read More
Favorites
Del.icio.us
Facebook
Furl
Magnolia
StumbleUpon
Google
Yahoo MyWeb
